BACKGROUND: The presence of at least one MC1R gene variant is associated with a reduction in age at melanoma diagnosis in families with CDKN2A mutations. OBJECTIVES: To describe dermoscopic features of early melanoma in CDKN2A gene mutation-positive Spanish individuals and to evaluate the possibility of a correlation between particular dermatoscopic pattern and MC1R gene variants. METHODS: Patients in whom a melanoma was diagnosed during specific follow up of high-risk individuals carrying CDKN2A mutations (with familial or personal history of previous melanoma) were included in this study. The decision to remove such melanomas was taken on the basis of history, clinical and dermoscopic evaluations including total body photography and digital dermoscopy. RESULTS: Of the nine patients included in this study, three were noncarriers of the red hair MC1R polymorphism, three patients had one red hair MC1R polymorphism and three patients had two red hair MC1R polymorphisms. On dermoscopic analysis of suspect melanocytic lesions we found that the mean +/- SD ABCD total dermoscopy score (TDS) was significantly higher in noncarriers of red hair MC1R polymorphisms than in carriers of two MC1R gene red hair variants (6.8 +/- 0.4 vs. 4.4 +/- 0.9; P = 0.014). CONCLUSIONS: Early melanomas in patients with two MC1R red hair variants may be difficult to diagnose definitively by dermoscopy because, in our limited experience, they show fewer colours and structures and have a lower TDS. In such melanomas, subtle atypical vessels and other changes detected by digital image follow up may be useful to confirm the diagnosis of melanoma. An integrated approach including clinical history and dermoscopic data (also considering additional information, such as the presence of atypical vessels) should be utilized in evaluating these high-risk patients. Further studies are necessary to confirm our suggestion.
BACKGROUND: The presence of at least one MC1R gene variant is associated with a reduction in age at melanoma diagnosis in families with CDKN2A mutations. OBJECTIVES: To describe dermoscopic features of early melanoma in CDKN2A gene mutation-positive Spanish individuals and to evaluate the possibility of a correlation between particular dermatoscopic pattern and MC1R gene variants. METHODS:Patients in whom a melanoma was diagnosed during specific follow up of high-risk individuals carrying CDKN2A mutations (with familial or personal history of previous melanoma) were included in this study. The decision to remove such melanomas was taken on the basis of history, clinical and dermoscopic evaluations including total body photography and digital dermoscopy. RESULTS: Of the nine patients included in this study, three were noncarriers of the red hair MC1R polymorphism, three patients had one red hair MC1R polymorphism and three patients had two red hair MC1R polymorphisms. On dermoscopic analysis of suspect melanocytic lesions we found that the mean +/- SD ABCD total dermoscopy score (TDS) was significantly higher in noncarriers of red hair MC1R polymorphisms than in carriers of two MC1R gene red hair variants (6.8 +/- 0.4 vs. 4.4 +/- 0.9; P = 0.014). CONCLUSIONS: Early melanomas in patients with two MC1R red hair variants may be difficult to diagnose definitively by dermoscopy because, in our limited experience, they show fewer colours and structures and have a lower TDS. In such melanomas, subtle atypical vessels and other changes detected by digital image follow up may be useful to confirm the diagnosis of melanoma. An integrated approach including clinical history and dermoscopic data (also considering additional information, such as the presence of atypical vessels) should be utilized in evaluating these high-risk patients. Further studies are necessary to confirm our suggestion.
Authors: Alon Scope; Michael A Marchetti; Ashfaq A Marghoob; Stephen W Dusza; Alan C Geller; Jaya M Satagopan; Martin A Weinstock; Marianne Berwick; Allan C Halpern Journal: J Am Acad Dermatol Date: 2016-06-17 Impact factor: 11.527
Authors: M C Fargnoli; F Sera; M Suppa; D Piccolo; M T Landi; A Chiarugi; C Pellegrini; S Seidenari; K Peris Journal: J Eur Acad Dermatol Venereol Date: 2014-03-04 Impact factor: 6.166
Authors: Richard A Sturm; Carly Fox; Phil McClenahan; Kasturee Jagirdar; Maider Ibarrola-Villava; Parastoo Banan; Nicola C Abbott; Gloria Ribas; Brian Gabrielli; David L Duffy; H Peter Soyer Journal: J Invest Dermatol Date: 2013-06-17 Impact factor: 8.551
Authors: John R Davies; Juliette Randerson-Moor; Kairen Kukalizch; Mark Harland; Rajiv Kumar; Srinivasan Madhusudan; Eduardo Nagore; Johan Hansson; Veronica Höiom; Paola Ghiorzo; Nelleke A Gruis; Peter A Kanetsky; Judith Wendt; Dace Pjanova; Susana Puig; Philippe Saiag; Dirk Schadendorf; Nadem Soufir; Ichiro Okamoto; Paul Affleck; Zaida García-Casado; Zighereda Ogbah; Aija Ozola; Paola Queirolo; Antje Sucker; Jennifer H Barrett; Remco van Doorn; D Timothy Bishop; Julia Newton-Bishop Journal: Pigment Cell Melanoma Res Date: 2012-03-16 Impact factor: 4.693
Authors: C Longo; V Barquet; E Hernandez; A A Marghoob; M Potrony; C Carrera; P Aguilera; C Badenas; J Malvehy; S Puig Journal: J Eur Acad Dermatol Venereol Date: 2020-07-28 Impact factor: 9.228
Authors: Susana Puig; Miriam Potrony; Francisco Cuellar; Joan Anton Puig-Butille; Cristina Carrera; Paula Aguilera; Eduardo Nagore; Zaida Garcia-Casado; Celia Requena; Rajiv Kumar; Gilles Landman; Bianca Costa Soares de Sá; Gisele Gargantini Rezze; Luciana Facure; Alexandre Leon Ribeiro de Avila; Maria Isabel Achatz; Dirce Maria Carraro; João Pedreira Duprat Neto; Thais C Grazziotin; Renan R Bonamigo; Maria Carolina W Rey; Claudia Balestrini; Enrique Morales; Montserrat Molgo; Renato Marchiori Bakos; Patricia Ashton-Prolla; Roberto Giugliani; Alejandra Larre Borges; Virginia Barquet; Javiera Pérez; Miguel Martínez; Horacio Cabo; Emilia Cohen Sabban; Clara Latorre; Blanca Carlos-Ortega; Julio C Salas-Alanis; Roger Gonzalez; Zulema Olazaran; Josep Malvehy; Celia Badenas Journal: Genet Med Date: 2015-12-17 Impact factor: 8.822